(Q42504729)

1 November 2017

Prostaglandin E2-EP4 receptor signalling promotes tumorigenic behaviour of HT-29 human colorectal cancer cells (English)

1 reference

1 November 2017

1 reference

1 reference

G Hawcroft

1

1 reference

1 November 2017

C W S Ko

series ordinal

2

1 reference

1 November 2017

M A Hull

series ordinal

3

1 reference

1 November 2017

language of work or name

English

0 references

publication date

20 November 2006

1 reference

1 November 2017

14

1 reference

inferred from page(s)

published in

Oncogene

1 reference

1 November 2017

26

1 reference

1 November 2017

21

1 reference

1 November 2017

3006-3019

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210113

1 November 2017

0 references

cites work

Microvascular permeability and number of tight junctions are modulated by cAMP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostanoid receptors: subtypes and signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Role of beta-arrestin 1 in the metastatic progression of colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E2 regulates cell migration via the intracellular activation of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Effect of prostaglandin E(2) on the proliferation, Ca(2+) mobilization and cAMP in HT-29 human colon adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Increased EP4 receptor expression in colorectal cancer progression promotes cell growth and anchorage independence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Cyclic AMP and acidic fibroblast growth factor have opposing effects on tight and adherens junctions in microvascular endothelial cells in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

EP(4) prostanoid receptor coupling to a pertussis toxin-sensitive inhibitory G protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Differential regulation of phosphorylation of the cAMP response element-binding protein after activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Phosphorylation of glycogen synthase kinase-3 and stimulation of T-cell factor signaling following activation of EP2 and EP4 prostanoid receptors by prostaglandin E2.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Effect of nonsteroidal anti-inflammatory drugs on beta-catenin protein levels and catenin-related transcription in human colorectal cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E2 protects gastric mucosal cells from apoptosis via EP2 and EP4 receptor activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Lack of cyclooxygenase-2 activity in HT-29 human colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

A ride on the ferrous wheel.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Cyclooxygenase-2: how good is it as a target for cancer chemoprevention?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Dual action of prostaglandin E2 on gastric acid secretion through different EP-receptor subtypes in the rat

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Imaging epidermal growth factor receptor phosphorylation in human colorectal cancer cells and human tissues

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Ligand binding specificities of the eight types and subtypes of the mouse prostanoid receptors expressed in Chinese hamster ovary cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Paracrine cyclooxygenase-2-mediated signalling by macrophages promotes tumorigenic progression of intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Eicosanoids and the large intestine

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Transcriptional regulation by the phosphorylation-dependent factor CREB

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

PGE2-induced hypertrophy of cardiac myocytes involves EP4 receptor-dependent activation of p42/44 MAPK and EGFR transactivation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Coordinate regulation of forskolin-induced cellular proliferation in macrophages by protein kinase A/cAMP-response element-binding protein (CREB) and Epac1-Rap1 signaling: effects of silencing CREB gene expression on Akt activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Cyclic AMP promotes cAMP-responsive element-binding protein-dependent induction of cellular inhibitor of apoptosis protein-2 and suppresses apoptosis of colon cancer cells through ERK1/2 and p38 MAPK.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Inhibition of apoptosis in normal and transformed intestinal epithelial cells by cAMP through induction of inhibitor of apoptosis protein (IAP)-2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Apical polarity in human colon carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E2 transactivates EGF receptor: a novel mechanism for promoting colon cancer growth and gastrointestinal hypertrophy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

EP2 and EP4 prostanoid receptor signaling

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3',5'-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellula

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E2 enhances intestinal adenoma growth via activation of the Ras-mitogen-activated protein kinase cascade

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Reawakening the cellular death program in neoplasia through the therapeutic blockade of IAP function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210113

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210113

1 reference

Dimensions Publication ID

1 November 2017

0 references

1 reference